Logo

Brady Davis, John Ellithorpe

Jan 05, 2017

DNAnexus expands its executive leadership team by appointing Brady Davis as vice president of strategy and marketing and John Ellithorpe as chief product officer. Davis comes to DNAnexus from Illumina, where he identified investment and acquisition opportunities, developed strategic partnerships, and led global product marketing for informatics. Before his work at Illumina, he led business development, strategy, and innovation for Oracle's Health Science Global Business Unit. Ellithorpe joins Illumina from Vantiq, where he served as chief product officer. Before his work at Vantiq, he co-founded Model N, where he served as chief technology officer and chief product officer.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.